Skip to main content
Log in

Successful chemotherapy in a patient with recurrent carcinoma of the urachus

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Urachal neoplasm generally has a poor prognosis, because of long latency period, extravesical progression and pathological predominant pattern of adenocarcinomas. We report a case of recurrent poorly differentiated carcinoma of urachal remnant, which responded well to combination systemic chemotherapy (methotrexate, vinblastine, doxorubicin and cisplatin: M-VAC). Our case was possibly of transitional cell origin. The patient has been symptom-free even 13 months after the first chemotherapy course.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sheldon, C. A., Ricardo, C. G., Williams, R. D., Fraley, E. E.: Malignant urachal lesions.J. Urol., 131, 1 (1984).

    PubMed  CAS  Google Scholar 

  2. Rankin, L. F., Allen, G. D., Yuppa, F. R., Pirozzi, M. J., Hajjar, J. R.: Carcinoma of the urachus in an adolescent: A case report.J. Urol., 150, 1472 (1993).

    PubMed  CAS  Google Scholar 

  3. Cornil, C., Reynolds, C. T., Kickham, C. J. E.: Carcinoma of urachus.J. Urol., 98, 93 (1967).

    PubMed  CAS  Google Scholar 

  4. Jacobo, E., Loening, S., Schmidt, J. D., Culp, D. A.: Primary adenocarcinoma of the bladder: A retrospective study of 20 patients.J. Urol., 117, 54 (1977).

    PubMed  CAS  Google Scholar 

  5. Bavendam, T. G., Kramolosky, E. V., Mitros, F. A.: Invasive adenocarcinoma of bladder: Response to cisplatinum, methotrexate, and vinblastine chemotherapy.Urology, 93, 53 (1989).

    Article  Google Scholar 

  6. Logothetis, C. J., Samuels, M. L., Ogden, S.: Chemotherapy for adenocarcinomas of bladder and urachal origin: 5-fluorouracil, doxorubicin, and mitomycin-C.Urology, 26, 252 (1985).

    Article  PubMed  CAS  Google Scholar 

  7. Sternberg, C. N., Yagoda, A., Scher, H. L., Watson, R. C., Ahmed, T., Weiselberg, L. R., Geller, N., Hollander, P. S., Herr, H. W., Sogani, P. C., Morse, M. J., Whitmore, W. F.: Preliminary result of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium.J. Urol., 133, 403 (1985).

    PubMed  CAS  Google Scholar 

  8. Mostofi, F. K., Sorbin, L. H., Torloni, H.: Histological Typing of Urinary Bladder Tumors. World Health Organization, 1973.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ichiyanagi, O., Sasagawa, I., Suzuki, Y. et al. Successful chemotherapy in a patient with recurrent carcinoma of the urachus. International Urology and Nephrology 30, 569–573 (1998). https://doi.org/10.1007/BF02550547

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02550547

Keywords

Navigation